Possible Role of Tamm‐Horsfall Glycoprotein in Calcium Oxalate Crystallisation
- 21 November 1989
- journal article
- research article
- Published by Wiley in British Journal of Urology
- Vol. 64 (5) , 463-467
- https://doi.org/10.1111/j.1464-410x.1989.tb05277.x
Abstract
Summary— The role of Tamm‐Horsfall glycoprotein (THGP) in the crystallisation of calcium oxalate was investigated. The results showed THGP to have a weak inhibitory effect on crystal growth. In contrast, urinary macromolecules showed a strong inhibitory effect. THGP should, therefore, not be considered the main component of urinary macromolecules which have a strong inhibitory effect on crystal growth. However, THGP did enhance crystal production in the early phase of crystallisation. It appears that THGP should be viewed as a promoter rather than an inhibitor of calcium oxalate crystallisation at physiological concentrations.This publication has 18 references indexed in Scilit:
- Macromolecules inhibit calcium oxalate crystal growth and aggregation in whole human urineClinica Chimica Acta; International Journal of Clinical Chemistry, 1987
- The effect of serum on the crystallization of calcium oxalate in whole human urine: Inhibition disguised as apparent promotionUrological Research, 1987
- Crystal inhibition: the effects of polyanions on calcium oxalate crystal growthClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- Effect of Macromolecules and of Sodium Dodecyl Sulphate upon Precipitation of Calcium Oxalate and Phosphate from Whole UrineUrologia Internationalis, 1984
- Uromucoid Excretion of Normal Individuals and Stone FormersBritish Journal of Urology, 1975
- Inhibitors of the growth and aggregation of calcium oxalate crystals in vitroClinica Chimica Acta; International Journal of Clinical Chemistry, 1973
- Über die HarnkolloideUrologia Internationalis, 1958
- BIOCOLLOIDS OF URINE IN HEALTH AND IN CALCULOUS DISEASE. II. ELECTROPHORETIC AND BIOCHEMICAL STUDIES OF A MUCOPROTEIN INSOLUBLE IN MOLAR SODIUM CHLORIDE 1Journal of Clinical Investigation, 1955